Eutilogics, Inc. is a clinical-stage biotechnology company located in San Diego, California. We are focused on the research and development of innovative T cell therapeutics for cancer.
Our proprietary approach demonstrated that our autologous adoptive T cell therapy has excellent safety and produced signs of compelling efficacy also in solid tumors. In the absence of any drug-related SAEs, we achieved CRs in brain cancers, NKT Lymphomas, and tumor regressions in NSCLC and breast cancers.
Our second therapy is based on our MVR CAR-T cell therapy approach that has produced complete cancer elimination in humanized in vivo models.
Our proprietary approach demonstrated that our autologous adoptive T cell therapy has excellent safety and produced signs of compelling efficacy also in solid tumors. In the absence of any drug-related SAEs, we achieved CRs in brain cancers, NKT Lymphomas, and tumor regressions in NSCLC and breast cancers.
Our second therapy is based on our MVR CAR-T cell therapy approach that has produced complete cancer elimination in humanized in vivo models.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
4-1BB CTL
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
